Patents by Inventor Jacob G. Kirkland

Jacob G. Kirkland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233563
    Abstract: Methods of treatment based on a neoplasm's responsiveness to anthracycline are provided. Chromatin accessibility or expression levels of chromatin regulatory genes are used in some instances to determine whether a neoplasm will respond to anthracycline treatment. Anthracyclines are utilized to treat various individuals' neoplasms and cancers, as determined by their anthracycline responsiveness.
    Type: Application
    Filed: March 30, 2020
    Publication date: July 28, 2022
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Gerald R. Crabtree, Christina Curtis, Jose A. Seoane Fernandez, Jacob G. Kirkland